Seungjun Ahn

Dr. Seungjun Ahn


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Ophthalmology
Verified
Journal Article
Closed access
CBChandrakumar Balaratnasingam
Chandrakumar Balaratnasingam
MIMaiko Inoue
Maiko Inoue
SASeungjun Ahn
Seungjun Ahn
JMJesse McCann
Jesse McCann
EDElona Dhrami-Gavazi
Elona Dhrami-Gavazi
KFK. Bailey Freund
K. Bailey Freund

10 September 2025 in Oral Oncology
Verified
Journal Article
Open access
JLJ.T. Lovett
J.T. Lovett
WWW.H. Westra
W.H. Westra
SRS. Roof
S. Roof
RBR.L. Bakst
R.L. Bakst
KSKunal Sindhu
Kunal Sindhu
MPM. Posner
M. Posner
Patients with HPV oropharyngeal cancer will live for decades with the sequelae of therapy, including radiation induced second primary cancers (SP). This study reviews and reports the incidence and outcomes of in-field SPs from the Quarterback Trials (QT) where molecular testing confirmed HPV status at diagnosis and recurrence. Patients in the QT had <20 pack-year smoking history, locally advanced disease, and molecularly confirmed HPV status. All patients received TPF induction chemotherapy (IC). Responders were treated on protocol with reduced-dose (RD, 5600 cGy) or standard-dose (SD, 7000 cGy) chemoradiotherapy (CRT). Recurrences and SPs were confirmed by biopsy and molecular testing. Of the 60 eligible patients consented, 13 received SD (8 randomized to SD, 4 with inadequate response to IC, 1 withdrew consent). There were 7 HPV+ LRFs (1 SD, 6 RD) and 4 molecularly confirmed in-field non-HPV SPs (2 SD, 2 RD). All SP tumors were p53-mutated and HPV-negative. Median time to LRF and SP was 8 and 66 months, respectively. Median survival after LRF or SP was 11 months and 18+ months, respectively. Non-HPV SPs are not uncommon in HPV+ non-smoking patients and occurred more frequently with SD treatment, suggesting a radiation dose-dependent effect. SPs presented symptomatically. SPs are likely to become a major cause of mortality in this population over time, underscoring the need for molecular testing to guide surveillance and treatment decisions. This is especially relevant for analysis of outcomes in de-escalation trials.

31 July 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
SASeungjun Ahn
Seungjun Ahn
EOEun Jeong Oh
Eun Jeong Oh
MSMatthew I. Saleem
Matthew I. Saleem
TTTristan Tham
Tristan Tham

20 January 2026 in Oral Oncology
Verified
Journal Article
Closed access
JLJ.T. Lovett
J.T. Lovett
MWM.T. Wotman
M.T. Wotman
WWW.H. Westra
W.H. Westra
SASeungjun Ahn
Seungjun Ahn
VGV. Gupta
V. Gupta
MPM. Posner
M. Posner

22 December 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
SASeungjun Ahn
Seungjun Ahn
SOMNATH DATTASOMNATH DATTA
SOMNATH DATTA
The SOHPIE R package implements a novel functionality for “multivariable” differential co-abundance network (DN, hereafter) analyses of microbiome data. It incorporates a regression approach that adjusts for additional covariates for DN analyses. This distinguishes from previous prominent approaches in DN analyses such as MDiNE and NetCoMi which do not feature a covariate adjustment of finding taxa that are differentially connected (DC, hereafter) between individuals with different clinical and phenotypic characteristics. SOHPIE with a vignette is available on CRAN repository https://CRAN.R-project.org/package=SOHPIE and published under General Public License (GPL) version 3 license.

18 March 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SASeungjun Ahn
Seungjun Ahn
SOMNATH DATTASOMNATH DATTA
SOMNATH DATTA
Background: A recent breakthrough in differential network (DN) analysis of microbiome data has been realized with the advent of next-generation sequencing technologies. The DN analysis disentangles the microbial co-abundance among taxa by comparing the network properties between two or more graphs under different biological conditions. However, the existing methods to the DN analysis for microbiome data do not adjust for other clinical differences between subjects.Results: We propose a Statistical Approach via Pseudo-value Information and Estimation for Differential Network Analysis (SOHPIE-DNA) that incorporates additional covariates such as continuous age and categorical BMI. SOHPIE-DNA is a regression technique adopting jackknife pseudo-values that can be implemented readily for the analysis. We demonstrate through simulations that SOHPIE-DNA consistently reaches higher recall and F1-score, while maintaining similar precision and accuracy to existing methods (NetCoMi and MDiNE). Lastly, we apply SOHPIE-DNA on two real datasets from the American Gut Project and the Diet Exchange Study to showcase the utility. The analysis of the Diet Exchange Study is to showcase that SOHPIE-DNA can also be used to incorporate the temporal change of connectivity of taxa with the inclusion of additional covariates. As a result, our method has found taxa that are related to the prevention of intestinal inflammation and severity of fatigue in advanced metastatic cancer patients.Conclusion: SOHPIE-DNA is the first attempt of introducing the regression framework for the DN analysis in microbiome data. This enables the prediction of characteristics of a connectivity of a network with the presence of additional covariate information in the regression. The package with a vignette of our methodology is available through the CRAN repository (https://CRAN.R-project.org/package=SOHPIE), named SOHPIE (pronounced asSofie). The source code and user manual can be found athttps://github.com/sjahnn/SOHPIE-DNA.